Tri-State Urologic Services is a clinical research site located in Cincinnati, Ohio, United States 45212.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Tri-State Urologic Services has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Metastatic Castration-Resistant Prostate Cancer, Prostatic Intraepithelial Neoplasia.
Sponsors: POINT Biopharma, a wholly owned subsidiary of Eli Lilly and Company, GTx.
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Tri-State Urologic Services has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Tri-State Urologic Services has 2 clinical trials on record, with 1 currently active. Their work covers Metastatic Castration-Resistant Prostate Cancer, Prostatic Intraepithelial Neoplasia.
Tri-State Urologic Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.